{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:51:39Z","timestamp":1790628699360,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,9]]},"abstract":"<jats:p>\n                    ABO-haemolytic disease of the fetus and newborn remains the leading cause of neonatal hyperbilirubinaemia; however, a reliable antenatal predictor is currently lacking. This study aimed to investigate whether the combination of maternal soluble vascular-endothelial cadherin (sVE-Cadherin) levels with immunoglobulin \u03b3 (IgG) anti-A\/B titers enhances prenatal detection of ABO-haemolytic disease of the fetus and newborn. We conducted a case-control study involving blood group O Rh(D)-positive mothers, categorized based on the occurrence of ABO hemolytic disease in their newborns. The maternal sVE-cadherin levels and anti-A\/B IgG titers in the 2 groups were compared and analyzed. Additionally, we analyzed their correlation with total bilirubin levels in infants and assessed their diagnostic value for the prenatal detection of ABO hemolytic disease. The sVE-cadherin levels and anti-A\/B IgG titers of pregnant women in the ABO hemolytic disease group were significantly higher than those observed in the control group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). A positive correlation was found between sVE-cadherin levels and total bilirubin (\n                    <jats:italic toggle=\"yes\">R<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    \u2005=\u20050.503,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) in the ABO hemolytic disease cohort. The area under the curve (AUC) for the sVE-cadherin level was 0.844, with a sensitivity of 84.91% and specificity of 70.00%. For the anti-A\/B IgG titer, the AUC was 0.897, with a sensitivity of 96.23% and specificity of 72.73%. When combined for diagnosis, these metrics yielded an AUC of 0.923, a sensitivity of 95.24%, and a specificity of 86.84%. Maternal sVE-cadherin levels along with anti-A\/B IgG titers provide significant reference values for prenatal diagnosis of ABO hemolytic disease; together, they demonstrate excellent joint diagnostic efficacy.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047146","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:02:39Z","timestamp":1767988959000},"page":"e47146","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Dual-biomarker strategy for prenatal prediction of ABO hemolytic disease: Maternal sVE-cadherin and anti-A\/B IgG titer"],"prefix":"10.1097","volume":"105","author":[{"given":"Dan-Dan","family":"Jiang","sequence":"first","affiliation":[{"name":"Qingdao West Coast New Area District People\u2019s Hospital, Qingdao, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6329-2555","authenticated-orcid":false,"given":"Jian-Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Qingdao Blood Center, Qingdao, Shandong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Chun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Qingdao West Coast New Area District People\u2019s Hospital, Qingdao, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000189239","article-title":"Correlation of Fc(gamma)RIIa (CD32) polymorphism and IgG antibody subclasses in hemolytic disease of newborn.","volume":"96","author":"Wu","year":"2009","journal-title":"Neonatology"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3163\/1536-5050.96.3.002","article-title":"Addressing hemolysis in infants due to mother-infant ABO blood incompatibility.","volume":"96","author":"Martin","year":"2008","journal-title":"J Med Library Assoc"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/lt.21752","article-title":"Overcoming the ABO incompatibility barrier.","volume":"15","author":"Freeman","year":"2009","journal-title":"Liver Transpl"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5455\/msm.2013.25.255-258","article-title":"Occurrence of ABO and RhD incompatibility with Rh-negative mothers.","volume":"25","author":"Izetbegovic","year":"2013","journal-title":"Mater Sociomed"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12288-012-0186-3","article-title":"Intravenous immunoglobulin G treatment in ABO hemolytic disease of the newborn, is it Myth or Real?","volume":"30","author":"Beken","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R6-20260805","first-page":"628","article-title":"Investigation on the clinical value of serum IgG anti-A (B) antibody titer of O-type puerperant in the early diagnosis and treatment of neonatal hemolytic disease.","volume":"31","author":"Qi","year":"2018","journal-title":"Chin J Blood Transfusion"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"64","DOI":"10.21307\/immunohematology-2021-009","article-title":"Statistical model for the prediction of ABO hemolytic disease in the fetus and newborn in India.","volume":"37","author":"Patale","year":"2021","journal-title":"Immunohematology"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3233\/CH-211290","article-title":"ABO blood group and skin cancers.","volume":"81","author":"Jacoub","year":"2022","journal-title":"Clin Hemorheol Microcirc"},{"key":"R9-20260805","first-page":"622","article-title":"The advances and application of ABO Blood group genotyping technology.","volume":"30","author":"Li","year":"2022","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"R10-20260805","first-page":"10","article-title":"CD144+ endothelial microparticles are a marker of endothelial injury in neonatal ABO blood group incompatibility.","volume":"12","author":"Awad","year":"2014","journal-title":"Blood Transfus"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1177\/0300060519870947","article-title":"Evaluation of endothelial microparticles as a prognostic marker in the hemolytic disease of newborns in China.","volume":"47","author":"Zhu","year":"2019","journal-title":"J Int Med Res"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1242\/jcs.179960","article-title":"VE-cadherin facilitates bone morphogenetic protein-induced endothelial cell permeability and signaling.","volume":"129","author":"Benn","year":"2016","journal-title":"J Cell Sci"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.transci.2012.04.001","article-title":"Foetal\/neonatal alloimmune thrombocytopenia in Egypt; human platelet antigen genotype frequencies and antibody detection and follow-up in pregnancies.","volume":"47","author":"Husebekk","year":"2012","journal-title":"Transfus Apher Sci"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41390-020-01232-5","article-title":"Prediction of the hemolytic activity of ABO disease in newborns using pre- and perinatal quantification of maternal anti-A\/anti-B IgG titers.","volume":"90","author":"Krog","year":"2021","journal-title":"Pediatr Res"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/15513815.2015.1075632","article-title":"Screening of maternal IgG anti-A and anti-B titer levels predicting ABO hemolytic disease of newborns: a meta-analysis.","volume":"34","author":"Li","year":"2015","journal-title":"Fetal Pediatr Pathol"},{"key":"R18-20260805","first-page":"1532","article-title":"Analysis of the correlations between IgG titers of pregnant women and neonatal hemolytic complications of different blood groups.","volume":"25","author":"Ye","year":"2017","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"R19-20260805","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/art.21350","article-title":"Microparticles as regulators of Inflammation: novel players of cellular crosstalk in rheumatic diseases.","volume":"52","author":"Distler","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R20-20260805","doi-asserted-by":"crossref","first-page":"9411137","DOI":"10.1155\/ancp\/9411137","article-title":"P-Selectin, vascular endothelial cadherin, and vascular cell adhesion molecule-1 as novel biomarkers for ABO hemolytic disease of the fetus and newborn.","volume":"2025","author":"Tang","year":"2025","journal-title":"Analytical Cell Pathol (Amsterdam)"},{"key":"R21-20260805","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/NPM-15814111","article-title":"Predictive value of cord blood bilirubin for hyperbilirubinemia in neonates at risk for maternal-fetal blood group incompatibility and hemolytic disease of the newborn.","volume":"8","author":"Calkins","year":"2015","journal-title":"J Neonatal Perinatal Med"},{"issue":"Suppl 2(0","key":"R22-20260805","first-page":"S47","article-title":"Pathogenesis and mechanisms of antibody-mediated hemolysis.","volume":"55","author":"Flegel","year":"2015","journal-title":"Transfusion"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T17:02:11Z","timestamp":1785949331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047146","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"2025-07-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}